Cardurion logo - click to return to the homepage

Cardurion Pharmaceuticals Announces Appointment of Chris Morabito, M.D., as Chief Medical Officer

 Appointment reflects growing strength and diversity of Cardurion’s pipeline July 08, 2020 08:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Cardurion Pharmaceuticals, Inc. (Cardurion), a Boston-based, clinical-stage biotechnology company focused on discovering and developing next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases, today announced the appointment of Chris Morabito, M.D., as chief medical officer […]

This site uses cookies and third-party scripts to provide certain services. View Privacy Policy

Skip to content